{\rtf1\ansi\deff0\deftab360

{\fonttbl
{\f0\fswiss\fcharset0 Arial}
{\f1\froman\fcharset0 Times New Roman}
{\f2\fswiss\fcharset0 Verdana}
{\f3\froman\fcharset2 Symbol}
}

{\colortbl;
\red0\green0\blue0;
}

{\info
{\author Biblio 7.x}{\operator }{\title Biblio RTF Export}}

\f1\fs24
\paperw11907\paperh16839
\pgncont\pgndec\pgnstarts1\pgnrestart
R. P.  Samal, Khedkar, V. M., Pissurlenkar, R. R. S., Bwalya, A. Gono, Tasdemir, D., Joshi, R. A., Rajamohanan, P. R., Puranik, V. G., and Coutinho, E. C., ?Design, synthesis, structural characterization by IR, 1H, 13C, 15N, 2D-NMR, X-ray diffraction and evaluation of a new class of phenylaminoacetic acid benzylidene hydrazines as pfENR inhibitors?, Chemical Biology & Drug Design, vol. 81, no. 6, pp. 715-729, 2013.\par \par N. C.  Desai, Kotadiya, G. M., Trivedi, A. R., Khedkar, V. M., and Jha, P. C., ?Synthesis, biological valuation, and QSAR studies of novel pyrazole bearing pyridyl oxadiazole analogues as potential antimicrobial agents?, Medicinal Chemistry Research, vol. 25, no. 4, pp. 712-727, 2016.\par \par P.  Miniyar, Mahajan, A., Anuse, D., Kumar, A., Barmade, M., Sarkar, D., Arkile, M., and Khedkar, V., ?Recursive partitioning analysis and anti-tubercular screening of 3-aminopyrazine-2-carbohydrazide derivatives?, Letters in Drug Design & Discovery, vol. 16, no. 11, pp. 1264-1275, 2019.\par \par R. Balasaheb Aher and Sarkar, D., ?2D-QSAR modeling and two-fold classification of 1,2,4-triazole derivatives for antitubercular potency against the dormant stage of Mycobacterium tuberculosis?, Molecular Diversity, vol. 26, no. 2, pp. 1227-1242, 2021.\par \par T. S.  Chitre, Asgaonkar, K. D., Vikhe, A. B., Patil, S. M., Garud, D. R., Khedkar, V. M., Sarkar, D., Nawale, L. U., and Yeware, A., ?In silico studies, synthesis and antitubercular activity of some novel quinoline - azitidinone derivatives?, Current Computer-Aided Drug Design, vol. 17, no. 1, pp. 134-143, 2021.\par \par P. D.  Kunde, Ramkumar, S., Kamble, S. P., RaviKumar, A., Kulkarni, B. D., and V. Kumar, R., ?On the use of electronegativity and electron affinity based pseudo-molecular field descriptors in developing correlations for quantitative structure-activity relationship modeling of drug activities?, Chemical Biology & Drug Design, vol. 98, no. 2, pp. 258-269, 2021.\par \par }